Christoph Berger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christoph Berger has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
David Nadal
† Division of Infectious Diseases, University of Zürich Children's Hospital, Zürich, Switzerland
3 shared publicationsWalter Zingg
Division of Infectious Diseases, University Children's Hospital, Switzerland
3 shared publicationsBernhard Frey
2 shared publicationsChristian Kellenberger
Department of Radiology, University Children's Hospital, Switzerland
2 shared publications- David Nadal
Division of Infectious Diseases, University Children's Hospital of Zurich, Zurich, Switzerland
2 shared publications Felix Grimm
Institute of Parasitology, University of Zürich, Switzerland
2 shared publications
Latest Publications
- 1 March 2014
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 33 (3) , 325-328
Unrecognized Pediatric Adult-type Tuberculosis Puts School Contacts At Risk
Adolescents with an immigrant background who are from tuberculosis high-incidence regions were at highest risk to develop adult-type tuberculosis disease in a low-incidence region during a 20-year period. If diagnosis and treatment were delayed up to 6 months, latent tuberculosis infection was detected in almost half of the affected individuals’ school contacts.
- 1 March 2014
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 33 (3) , 325-328
Unrecognized Pediatric Adult-type Tuberculosis Puts School Contacts At Risk
Adolescents with an immigrant background who are from tuberculosis high-incidence regions were at highest risk to develop adult-type tuberculosis disease in a low-incidence region during a 20-year period. If diagnosis and treatment were delayed up to 6 months, latent tuberculosis infection was detected in almost half of the affected individuals’ school contacts.
- Open Access
- 25 April 2012
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 19 (3) , 158-162
Profile of Travel‐Associated Illness in Children, Zürich, Switzerland
- 25 April 2012
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 19 (3) , 158-162
Open AccessProfile of Travel‐Associated Illness in Children, Zürich, Switzerland
- Open Access
- 10 January 2007
- Published by Springer Nature in Molecular Cancer
- Vol. 6 (1) , 1-3
Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells
Epigenetic silencing of regulatory genes by aberrant methylation contributes to tumorigenesis. DNA methyltransferase inhibitors (DNMTI) represent promising new drugs for anti-cancer therapies. The DNMTI 5-Azacytidine is effective against myelodysplastic syndrome, but induces switching of latent to lytic Epstein-Barr virus (EBV) in vitro and results in EBV DNA demethylation with the potential of induction of lytic EBV in vivo. This is of considerable concern given that recurrent lytic EBV has been linked with an increased incidence of EBV-associated lymphomas. Based on the distinct properties of action we hypothesized that the newer DNMTI Zebularine might differ from 5-Azacytidine in its potential to induce switching from latent to lytic EBV. Here we show that both 5-Azacytidine and Zebularine are able to induce expression of E-cadherin, a cellular gene frequently silenced by hypermethylation in cancers, and thus demonstrate that both DNMTI are active in our experimental setting consisting of EBV-harboring Burkitt's lymphoma Akata cells. Quantification of mRNA expression of EBV genes revealed that 5-Azacytidine induces switching from latent to lytic EBV and, in addition, that the immediate-early lytic infection progresses to early and late lytic infection. Furthermore, 5-Azacytidine induced upregulation of the latent EBV genes LMP2A, LMP2B, and EBNA2 in a similar fashion as observed following switching of latent to lytic EBV upon cross-linking of the B-cell receptor. In striking contrast, Zebularine did not exhibit any effect neither on lytic nor on latent EBV gene expression. Thus, Zebularine might be safer than 5-Azacytidine for the treatment of cancers in EBV carriers and could also be applied against EBV-harboring tumors, since it does not induce switching from latent to lytic EBV which may result in secondary EBV-associated malignancies.
- 10 January 2007
- Published by Springer Nature in Molecular Cancer
- Vol. 6 (1) , 1-3
Open AccessZebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells
Epigenetic silencing of regulatory genes by aberrant methylation contributes to tumorigenesis. DNA methyltransferase inhibitors (DNMTI) represent promising new drugs for anti-cancer therapies. The DNMTI 5-Azacytidine is effective against myelodysplastic syndrome, but induces switching of latent to lytic Epstein-Barr virus (EBV) in vitro and results in EBV DNA demethylation with the potential of induction of lytic EBV in vivo. This is of considerable concern given that recurrent lytic EBV has been linked with an increased incidence of EBV-associated lymphomas. Based on the distinct properties of action we hypothesized that the newer DNMTI Zebularine might differ from 5-Azacytidine in its potential to induce switching from latent to lytic EBV. Here we show that both 5-Azacytidine and Zebularine are able to induce expression of E-cadherin, a cellular gene frequently silenced by hypermethylation in cancers, and thus demonstrate that both DNMTI are active in our experimental setting consisting of EBV-harboring Burkitt's lymphoma Akata cells. Quantification of mRNA expression of EBV genes revealed that 5-Azacytidine induces switching from latent to lytic EBV and, in addition, that the immediate-early lytic infection progresses to early and late lytic infection. Furthermore, 5-Azacytidine induced upregulation of the latent EBV genes LMP2A, LMP2B, and EBNA2 in a similar fashion as observed following switching of latent to lytic EBV upon cross-linking of the B-cell receptor. In striking contrast, Zebularine did not exhibit any effect neither on lytic nor on latent EBV gene expression. Thus, Zebularine might be safer than 5-Azacytidine for the treatment of cancers in EBV carriers and could also be applied against EBV-harboring tumors, since it does not induce switching from latent to lytic EBV which may result in secondary EBV-associated malignancies.
- Open Access
- 6 June 2006
- Published by Springer Nature in Virology Journal
- Vol. 3 (1) , 43
Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray
Background: The Epstein-Barr virus (EBV) is associated with lymphoid malignancies, including Burkitt's lymphoma (BL), and can transform human B cells in vitro. EBV-harboring cell lines are widely used to investigate lymphocyte transformation and oncogenesis. Qualitative EBV gene expression has been extensively described, but knowledge of quantitative transcription is lacking. We hypothesized that transcription levels ofEBNA1, the gene essential for EBV persistence within an infected cell, are similar in BL cell lines.Results: To compare quantitative gene transcription in the BL cell lines Namalwa, Raji, Akata, Jijoye, and P3HR1, we developed an oligonucleotide microarray chip, including 17 housekeeping genes, six latent EBV genes (EBNA1,EBNA2,EBNA3A,EBNA3C,LMP1,LMP2), and four lytic EBV genes (BZLF1,BXLF2,BKRF2,BZLF2), and used the cell line B95.8 as a reference for EBV gene transcription. Quantitative polymerase chain reaction assays were used to validate microarray results. We found that transcription levels of housekeeping genes differed considerably among BL cell lines. Using a selection of housekeeping genes with similar quantitative transcription in the tested cell lines to normalize EBV gene transcription data, we showed that transcription levels ofEBNA1were quite similar in very different BL cell lines, in contrast to transcription levels of other EBV genes. As demonstrated with Akata cells, the chip allowed us to accurately measure EBV gene transcription changes triggered by treatment interventions.Conclusion: Our results suggest uniformEBNA1transcription levels in BL and that microarray profiling can reveal novel insights on quantitative EBV gene transcription and its impact on lymphocyte biology.
- 6 June 2006
- Published by Springer Nature in Virology Journal
- Vol. 3 (1) , 43
Open AccessQuantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray
Background: The Epstein-Barr virus (EBV) is associated with lymphoid malignancies, including Burkitt's lymphoma (BL), and can transform human B cells in vitro. EBV-harboring cell lines are widely used to investigate lymphocyte transformation and oncogenesis. Qualitative EBV gene expression has been extensively described, but knowledge of quantitative transcription is lacking. We hypothesized that transcription levels ofEBNA1, the gene essential for EBV persistence within an infected cell, are similar in BL cell lines.Results: To compare quantitative gene transcription in the BL cell lines Namalwa, Raji, Akata, Jijoye, and P3HR1, we developed an oligonucleotide microarray chip, including 17 housekeeping genes, six latent EBV genes (EBNA1,EBNA2,EBNA3A,EBNA3C,LMP1,LMP2), and four lytic EBV genes (BZLF1,BXLF2,BKRF2,BZLF2), and used the cell line B95.8 as a reference for EBV gene transcription. Quantitative polymerase chain reaction assays were used to validate microarray results. We found that transcription levels of housekeeping genes differed considerably among BL cell lines. Using a selection of housekeeping genes with similar quantitative transcription in the tested cell lines to normalize EBV gene transcription data, we showed that transcription levels ofEBNA1were quite similar in very different BL cell lines, in contrast to transcription levels of other EBV genes. As demonstrated with Akata cells, the chip allowed us to accurately measure EBV gene transcription changes triggered by treatment interventions.Conclusion: Our results suggest uniformEBNA1transcription levels in BL and that microarray profiling can reveal novel insights on quantitative EBV gene transcription and its impact on lymphocyte biology.
- 13 May 2004
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 163 (7) , 422-423
Withholding initial vancomycin in febrile neutropenia despite implanted catheters
- 13 May 2004
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 163 (7) , 422-423
Withholding initial vancomycin in febrile neutropenia despite implanted catheters
- Open Access
- 19 November 2003
- Published by CLOCKSS Archive in Forum Médical Suisse ‒ Swiss Medical Forum
- Vol. 3 (47) , 1149
Vorgehen bei Tonsillopharyngitits
Le journal publie des articles contribuant à la formation continue et relatifs à toutes les disciplines de la médecine. Le SMF est la revue de formation professionnelle médicale la plus lue en Suisse.
- 19 November 2003
- Published by CLOCKSS Archive in Forum Médical Suisse ‒ Swiss Medical Forum
- Vol. 3 (47) , 1149
Open AccessVorgehen bei Tonsillopharyngitits
Le journal publie des articles contribuant à la formation continue et relatifs à toutes les disciplines de la médecine. Le SMF est la revue de formation professionnelle médicale la plus lue en Suisse.
- 1 October 2003
- Published by Hogrefe Publishing Group in Therapeutische Umschau
- Vol. 60 (10) , 625-630
Infektiöse Mononukleose
Infectious mononucleosis (IM) is the manifestation of primary infection with Epstein-Barr virus (EBV). EBV persisting after infection for a life-time infects > 90% of the adult population. Primary infection mostly asymptomatic in young children manifests in teenagers and young adults in about 50% as IM with fever, sore throat, generalized lymphadenopathy, frequently hepatosplenomegaly and blood lymphocytosis with the characteristic atypical lymphocytes. Clinical presentation, typical lymphocytosis and heterophile antibodies are diagnostic. Atypical cases may need to be confirmed by specific serology. IM is a self-limiting lymphoproliferation regressing within 2-3 weeks. Complications are rare and may involve many different organs. Severe cases are very uncommon, except in patients with inborn or acquired immunodeficiency carrying a substantially higher risk for severe courses, pogredient lymphoproliferation and lymphoma.
- 1 October 2003
- Published by Hogrefe Publishing Group in Therapeutische Umschau
- Vol. 60 (10) , 625-630
Infektiöse Mononukleose
Infectious mononucleosis (IM) is the manifestation of primary infection with Epstein-Barr virus (EBV). EBV persisting after infection for a life-time infects > 90% of the adult population. Primary infection mostly asymptomatic in young children manifests in teenagers and young adults in about 50% as IM with fever, sore throat, generalized lymphadenopathy, frequently hepatosplenomegaly and blood lymphocytosis with the characteristic atypical lymphocytes. Clinical presentation, typical lymphocytosis and heterophile antibodies are diagnostic. Atypical cases may need to be confirmed by specific serology. IM is a self-limiting lymphoproliferation regressing within 2-3 weeks. Complications are rare and may involve many different organs. Severe cases are very uncommon, except in patients with inborn or acquired immunodeficiency carrying a substantially higher risk for severe courses, pogredient lymphoproliferation and lymphoma.
- Open Access
- 1 July 2003
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (1) , 129-130
A 7-Year-Old Girl with Dyspnea and Rash
Cystic echinococcosis, also known as cystic hydatid disease, is the most widespread and severe human cestode infection. It is common in Mediterranean countries
- 1 July 2003
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (1) , 129-130
Open AccessA 7-Year-Old Girl with Dyspnea and Rash
Cystic echinococcosis, also known as cystic hydatid disease, is the most widespread and severe human cestode infection. It is common in Mediterranean countries
- Open Access
- 1 July 2003
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (1) , 73-74
A 7-Year-Old Girl with Dyspnea and Rash
A 7-year-old Macedonian girl with severe dyspnea and a 3-day history of fever, cough, and malaise presented to a regional hospital. She had no history of lung disease or allergy. Chest radiographs (figure 1) showed a cavitary lesion within a consolidated right lower lobe, as well as a small pleural effusion. Pneumonia with lung abscess was suspected, and treatment with intravenous amoxicillin-clavulanate (100 mg/kg t.i.d.) was started. After receiving amoxicillin-clavulanate for 10 min, the patient developed an urticarial rash on her trunk and buttocks. On the assumption that this treatment was having an adverse effect, the antimicrobial treatment was switched to ceftriaxone (75 mg/kg per day). Because of aggravating dyspnea and hypoxemia over the next several hours, the patient was transferred to our tertiary hospital.
- 1 July 2003
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (1) , 73-74
Open AccessA 7-Year-Old Girl with Dyspnea and Rash
A 7-year-old Macedonian girl with severe dyspnea and a 3-day history of fever, cough, and malaise presented to a regional hospital. She had no history of lung disease or allergy. Chest radiographs (figure 1) showed a cavitary lesion within a consolidated right lower lobe, as well as a small pleural effusion. Pneumonia with lung abscess was suspected, and treatment with intravenous amoxicillin-clavulanate (100 mg/kg t.i.d.) was started. After receiving amoxicillin-clavulanate for 10 min, the patient developed an urticarial rash on her trunk and buttocks. On the assumption that this treatment was having an adverse effect, the antimicrobial treatment was switched to ceftriaxone (75 mg/kg per day). Because of aggravating dyspnea and hypoxemia over the next several hours, the patient was transferred to our tertiary hospital.
- 1 August 2001
- Published by Wiley in Journal of Medical Virology
- Vol. 64 (4) , 505-512
Dynamics of Epstein‐Barr virus DNA levels in serum during EBV‐associated disease
- 1 August 2001
- Published by Wiley in Journal of Medical Virology
- Vol. 64 (4) , 505-512
Dynamics of Epstein‐Barr virus DNA levels in serum during EBV‐associated disease